Sabra Health Care REIT (SBRA) Cash from Financing Activities (2011 - 2026)

Sabra Health Care REIT's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $52.1 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 151.46% year-over-year to $52.1 million; the TTM figure through Mar 2026 stood at $194.1 million (up 173.92% YoY), while the FY2025 annual figure was $40.8 million, up 122.45% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $52.1 million, up from -$100.9 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $206.2 million in Q3 2025, with the low at -$196.1 million in Q1 2023.
• The 5-year median for Cash from Financing Activities is -$46.4 million (2024), against an average of -$38.9 million.
• The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities jumped 2164.31% in 2022, then tumbled 978.33% in 2024.
• Sabra Health Care REIT's Cash from Financing Activities stood at -$13.5 million in 2022, then surged by 30.74% to -$9.4 million in 2023, then sank by 978.33% to -$101.0 million in 2024, then climbed by 0.07% to -$100.9 million in 2025, then jumped by 151.64% to $52.1 million in 2026.
• Business Quant data shows SBRA's Cash from Financing Activities at $52.1 million in Q1 2026, -$100.9 million in Q4 2025, and $206.2 million in Q3 2025.